You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 8, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Kei Miyakawa1,2,3,4, Yusuke Nakai2, Taichi Kameya5,6
1AIDS Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 208-0011, Japan.
CD46 regulates Hepatitis B virus (HBV) entry by controlling the expression of its receptor, sodium taurocholate co-transporting polypeptide (NTCP). Targeting CD46 with antibodies inhibits HBV infection.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: